*The search scope is limited to the products and news section of this site
*The search scope is limited to the products and news section of this site
On Jul. 25, Henan Genuine Biotech Co., Ltd. (hereinafter referred to as "Genuine Biotech") announced that the registration application of small-molecule oral drug Azvudine tablets, independently developed by the company for the treatment of COVID-19, has been granted conditional approval by the Nati...
Henan Genuine Biotech Co., Ltd. (hereinafter referred to as "Genuine Biotech") announced that the results of phase III clinical trial for registration of Azvudine tablets for the treatment of COVID-19 have met the expectations. Recently, a marketing application has been formally submitted to the Nat...
The "2021 Annual Selection of Pharmaceutical Innovation and Salvation Awards" held by Securities Times was officially announced on Apr. 20, and Henan Genuine Biotech Co., Ltd. (hereinafter referred to as "Genuine Biotech") received two awards. Azvudine was awarded the "Pharmaceutical Innovation Achi...
On Feb. 23, Henan Provincial Party Secretary Lou Yangsheng and his team visited Henan Genuine Biotech Co., Ltd. (hereinafter referred to as "Genuine Biotech") for research and guidance. The research was accompanied by Chen Xing, standing committee of Provincial Party Committee and Secretary-General,...
On Oct. 16, the inauguration ceremony for the first batch of provincial industrial research institutes and pilot bases in Henan Province was held in Zhengzhou. The ceremony was held for 10 provincial industrial research institutes and 8 provincial pilot bases, among which the Henan Modern Pharmaceut...
On Sep. 6, MENET released the "2020 Top 100 Innovation List Series for Biopharmaceutical Enterprises in China", and Genuine Biotech was ranked among the Top 100 List Series: "Top 30 Innovative Small-Molecule Pharmaceutical Enterprises in China" with its solid scientific research capacity.
On Aug. 26, Genuine Biotech Co., Ltd. announced the completion of $100 million Series B financing. This series of strategic financing was led by Efung Capital and Yingke PE, and followed by Desano, ABC Capital, and Fortune Financial Capital. The fund will be used for product R&D, clinical trial regi...
Recently, Genuine Biotech and Insilico Medicine, a leading AI drug discovery and development company in the industry, announced a strategic collaboration. According to the strategic cooperation agreement, both parties will start innovative R&D cooperation in the fields of antiviral and antitumor dru...
Copyright © 2022 河南真实生物科技有限公司 All Rights Reserved 京ICP备2021026784号-1
